Trials / Completed
CompletedNCT02708355
Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment
A Pilot Phase IV, Multicenter, Randomized, Double Blind, Placebo-Controlled, Parallel Study To Investigate The Correlation Between Ph Control And Heartburn Symptoms After 14 Days Of Proton Pump Inhibitor Treatment In Subjects With Frequent Heartburn
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 22 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study is to investigate the association between gastric acid suppression and relief of 24 hour heartburn following treatment with the proton pump inhibitor (PPI) drug esomeprazole in frequent heartburn patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole 20 mg | Esomeprazole 20 mg banded capsules (22.3 mg esomeprazole magnesium trihydrate) |
| DRUG | Placebo | Placebo capsules |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2016-03-15
- Last updated
- 2017-04-19
- Results posted
- 2017-04-19
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02708355. Inclusion in this directory is not an endorsement.